“Medicines and IP: Balancing Innovation and Access”
Video
Summary
No summary yet — a transcript has to be published before this proceeding can be summarised. Everything else on this page is already available.
Motions and votes
No recorded votes were published for this proceeding.
Witnesses (4)
- Ms. Krista Hessler Carver Partner Covington & Burling LLP
- Mr. Michael Carrier Professor Rutgers Law School Written testimony ↗
- Ms. Rachel Goode Senior Vice President Head of Legal and Intellectual Property Written testimony ↗
- Ms. Jamie Simpson Chief Policy Officer and Counsel Council for Innovation Promotion Written testimony ↗
Most witnesses are private citizens, academics and industry representatives who are not people CivicGate tracks — a name without a link is the normal case, not a missing record.
Documents (58)
- Supporting document A statement for the record from the Biotechnology Innovation Organization, submitted for the Record by Mr. Johnson of GA
- Supporting document A letter dated June 3, 2026, from Alliance for Aging Research to Representatives Issa and Johnson regarding the ETHIC Act, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A statement for the record from AARP, submitted for the Record by Mr. Johnson of GA
- Supporting document A statement for the record from the American Society of Health-System Pharmacists (ASHP), submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A statement for the record from the Biosimilars Forum, submitted for the Record by Mr. Johnson of GA
- Supporting document A statement for the record from the Council for Innovation Promotion, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A brief from the Center for American Principles titled, “Cap Issue Brief: Biopharmaceutical Patents”, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A statement for the record from the Center for American Principles, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A statement for the record from the Campaign for Sustainable Rx Pricing, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A statement for the record from the ERISA Industry Committee (ERIC), submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A statement for the record from Families USA, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A statement for the record from Luis Abinader of Generation Patient, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A statement for the record from Peyton Miles of Generation Patient, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A statement for the record from the National Association of Manufacturers, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A statement for the record from Patients for Affordable Drugs Now, submitted for the Record by Mr. Johnson of GA
- Supporting document A statement for the record from the U.S. Chamber of Commerce regarding the ETHIC Act, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document An opinion from the Supreme Court of the United States in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc., submitted for the Record by Mr. Issa of CA
- Supporting document A study from the United States Patent and Trademark Office titled, “Drug Patent and Exclusivity Study”, submitted for the Record by Mr. Kiley of CA
- Supporting document A letter dated June 2, 2026, from the Intellectual Property Owners Association to Representatives Issa and Johnson regarding the ETHIC Act, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A statement for the record from the Center for Medicine in the Public Interest, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A letter dated June 2, 2026, from the Alliance of U.S. Startups and Inventors for Jobs (USIJ) regarding the ETHIC Act, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA
- Supporting document A letter dated June 1, 2026, from the Taxpayers Protection Alliance to Representatives Issa and Johnson regarding the hearing on June 4, submitted for the Record by Mr. Issa of CA
- Supporting document A letter dated June 3, 2026, from the American Intellectual Property Law Association to Representatives Issa and Johnson, submitted for the Record by Mr. Issa of CA
- Supporting document A copy of HR 3269, the ETHIC Act, submitted for the Record by Mr. Issa of CA
- Supporting document A copy of HR 6485, the Skinny Labels, Big Savings Act, submitted for the Record by Mr. Issa of CA
- Supporting document A statement for the record from Blood Cancer United, submitted for the Record by Mr. Issa of CA
- Supporting document A statement for the record from Representative Arrington of Texas, submitted for the Record by Mr. Issa of CA
- Supporting document A statement for the record from NFIB, submitted for the Record by Mr. Issa of CA
- Supporting document A statement for the record from multiple organizations expressing support for the ETHIC Act, submitted for the Record by Mr. Issa of CA
- Supporting document A letter dated April 6, 2026, from multiple organizations to Chairman Jordan, Ranking Member Raskin, and Representatives Issa and Johnson regarding the ETHIC Act and the Skinny Labels, Big Savings Act, submitted for the Record by Mr. Issa of CA
- Supporting document A statement for the record from the Pharmaceutical Care Management Association, submitted for the Record by Mr. Issa of CA
- Supporting document A statement for the record from the Pacific Research Institute, submitted for the Record by Mr. Issa of CA
- Supporting document A statement for the record from We Work for Health, submitted for the Record by Mr. Issa of CA
- Supporting document A statement for the record from Dr. Anne Pritchett, submitted for the Record by Mr. Issa of CA
- Supporting document A statement for the record from Biocom, submitted for the Record by Mr. Issa of CA
- Supporting document A statement for the record from Public Citizen, submitted for the Record by Mr. Issa of CA
- Supporting document A statement for the record from the Association for Accessible Medicines and its Biosimilars Council (AAM), submitted for the Record by Mr. Issa of CA
- Supporting document A statement for the record from the U.S. Public Interest Research Group, submitted for the Record by Mr. Issa of CA
- Supporting document A study by Rachel Goode and Bernard Chao titled, "Biological patent thickets and delayed access to biosimilars, an American problem"
- Supporting document A statement for the record from Dr. Rachel Goode regarding the ETHIC Act
- Supporting document A study titled, "Biological Patent Thickets and Terminal Disclaimers"
- Supporting document A study from the University of Pittsburgh Law Review titled, "The Long Con: An Empirical Analysis of Pharmaceutical Patent Thickets"
- Questions for the record Questions for the record from Representatives Issa and Johnson for Mr. Carrier with Responses
- Questions for the record Questions for the record from Representatives Issa and Johnson for Dr. Goode with Responses
- Questions for the record Questions for the record from Representatives Issa and Johnson for Ms. Simpson with Responses
- Questions for the record Questions for the Record from Representatives Issa, Ross, and Johnson for Ms. Carver with Responses
- Witness document Witness Biography
- Witness document Witness Statement
- Witness document Witness Truth in Testimony
- Witness document Witness Biography
- Witness document Witness Statement
- Witness document Witness Truth in Testimony
- Witness document Witness Biography
- Witness document Witness Statement
- Witness document Witness Truth in Testimony
- Witness document Witness Biography
- Witness document Witness Statement
- Witness document Witness Truth in Testimony
Source: the official Congress.gov record for this event — https://www.congress.gov/event/119th-Congress/house-event/119346. Committee record: Committee record.